Assessing the REsponse Rate of Weekly Neo-adjuvanT pacliTAxel (Taxol) in Nigerian Women With Breast Cancer (ARETTA)
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 09 Feb 2018
At a glance
- Drugs Paclitaxel (Primary) ; Carboplatin; Cyclophosphamide; Epirubicin; Fluorouracil; Gonadotropin releasing hormone; Letrozole; Pertuzumab; Tamoxifen; Trastuzumab
- Indications Breast cancer
- Focus Therapeutic Use
- Acronyms ARETTA
- 06 Feb 2018 Planned initiation date changed from 1 Nov 2017 to 1 Nov 2018.
- 08 May 2017 Planned initiation date changed from 1 Apr 2017 to 1 Nov 2017.
- 02 Mar 2017 New trial record